
GLP-1 Drug Market: the rapid growth of the diabetes and obesity drugs market
The diabetes and obesity market is expanding rapidly, with GLP-1 agonists a key medication that is proven to lower blood sugar levels, they also suppress appetite and reduce calorie intake. J.P. Morgan Research forecasts that the GLP-1 market will exceed